CXCL14 and breast cancer: A study identified novel cell subpopulations with abnormally high CXCL14 expression levels in patients with breast cancer PL by transposase accessible chromatin (ATAC) sequencing (scATAC-seq) of breast cancer negative (NL) and positive lymph nodes (PL), and also identified potential regulators that may be associated with breast cancer lymph node metastasis, improving our understanding of the mechanism of lymph node metastasis of lymph node metastasis and provide a new prognostic marker for breast cancer lymphatic metastasis [64].